Related Experiment Video
Updated: Mar 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Omid Tavana1,2, Wei Gu1,2,3
1College of Physicians and Surgeons, Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
Abstract:
It is well established that both p53 and MDM2 are short-lived proteins whose stabilities are tightly controlled through ubiquitination-mediated degradation. Although numerous studies indicate that the MDM2 E3 ligase activity, as well as the protein-protein interaction between p53 and MDM2, is the major focus for this regulation, emerging evidence suggests that the deubiquitinase herpesvirus-associated ubiquitin-specific protease (HAUSP, also known as USP7) plays a critical role. Furthermore, HAUSP inhibition elevates p53 stability and might be beneficial for therapeutic purposes. In this review, we discuss the advances of this dynamic pathway and the contributions of positive and negative regulators affecting HAUSP activity. We also highlight the roles of HAUSP in cancer justifying the production of the first generation of HAUSP inhibitors.
Insights
The herpesvirus-associated ubiquitin-specific protease (HAUSP) regulates p53 stability. Inhibiting HAUSP increases p53 levels, offering potential cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- p53 and MDM2 are short-lived proteins regulated by ubiquitination-mediated degradation.
- MDM2 E3 ligase activity and p53-MDM2 interaction are key regulatory mechanisms.
- Emerging evidence highlights the critical role of deubiquitinase HAUSP (USP7) in this pathway.
Purpose of the Study:
- To review advances in the p53-MDM2-HAUSP regulatory pathway.
- To discuss positive and negative regulators of HAUSP activity.
- To highlight HAUSP's role in cancer and the development of inhibitors.
Main Methods:
- Literature review of studies on p53, MDM2, and HAUSP (USP7).
- Analysis of regulatory mechanisms controlling HAUSP activity.
- Examination of HAUSP's role in oncogenesis and therapeutic targeting.
Main Results:
- HAUSP (USP7) deubiquitinase activity is critical for p53 regulation.
- HAUSP inhibition enhances p53 protein stability.
- This pathway's dysregulation is implicated in cancer development.
Conclusions:
- HAUSP is a key regulator of p53 stability, distinct from MDM2's E3 ligase function.
- Targeting HAUSP offers a promising therapeutic strategy for cancer.
- The development of HAUSP inhibitors is a significant advancement in cancer therapy.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity

